The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the
agent of novel coronavirus 2019 (COVID‐19), has kept the globe in disquiets due to its …

Coronaviruses (CoVs) dincluding SARS-CoV-2, the cause of the current pandemic of
coronavirus disease 2019 (COVID-19) dhave a propensity for neuroinvasion [1, 2]; …

Anosmia was identified as a hallmark of COVID-19 early in the pandemic, however, with the
emergence of variants of concern, the clinical profile induced by SARS-CoV-2 infection has …

Many thanks for great interest in our published review (Wu et al., 2020). As we know, severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mainly infects the respiratory …

The respiratory condition COVID-19 arises in a human host upon the infection with SARS-
CoV-2, a coronavirus that was first acknowledged in Wuhan, China, at the end of December …

A recent study by Wu et al.(2020) discussed the neuroinvasive potential of SARS-CoV-2 on
the premises of a lack of pathological evidence of definite CNS infiltration, and a predilection …

The occurrence of anosmia, the loss or change in sense of smell, is one of the most common
symptoms of COVID-19 experienced by almost 53% of those affected. Several hypotheses …

The unexpected onset smell and taste disability was being recognized as a COVID-19
related symptom. Loss of smell might occur alone or be followed by other COVID-19 …

SARS-CoV-2 infection causes a wide spectrum of clinical manifestations in humans, and
olfactory dysfunction is one of the most predictive and common symptoms in COVID-19 …

Objectives The pandemic has affected over 182 million coronavirus disease 2019 (COVID-
19) cases worldwide. Accumulated evidence indicates that anosmia is one of the significant …